Teligent, Inc. TLGT

Teligent, Inc. DSO Ratio 2011-2026 | TLGT

Annual DSO Ratio Teligent, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
90.7	113	89.3	98.5	119	116	155	99.1	67.4	67.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
155	67.4	102

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Nymox Pharmaceutical Corporation NYMX	12.5	-	-19.68 %	$ 18.4 M	Canada
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.6	$ 0.9	-2.33 %	$ 6.62 M	China
ACADIA Pharmaceuticals ACAD	37.5	$ 21.96	-0.68 %	$ 3.64 B	USA
RedHill Biopharma Ltd. RDHL	358	$ 1.02	-0.49 %	$ 428 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 21.41	1.9 %	$ 1 B	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Kazia Therapeutics Limited KZIA	28.7	$ 12.26	3.72 %	$ 1.62 B	Australia
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	103	$ 4.08	0.25 %	$ 436 M	USA
Arcutis Biotherapeutics ARQT	106	$ 23.26	1.75 %	$ 2.96 B	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.44	-5.88 %	$ 383 M	Britain
BioXcel Therapeutics BTAI	103	$ 1.06	-3.64 %	$ 12.9 M	USA
CASI Pharmaceuticals CASI	87.4	-	-	$ 35.4 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 2.91	-1.36 %	$ 4.79 M	Israel
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA